“Biofilm” is generally a group of biotic organisms which have a protective matrix of metallo-mineral and organic molecule coating. This complex protects the organisms from anti-infective therapies and create a “super-biotic” organism colony. A biofilm can form almost anywhere where water is present (The human gut, bloodstream teeth – the sticky coating on teeth after not brushing your teeth is Biofilm.) In most cases the biofilm matrix is able to protect the organism colony from even the highest and strongest doses of Antibiotics. Knowledge of the interference in clinical outcomes and methods of treating biofilms is critical to medical practice.

Learning Objectives:

• Update clinical knowledge of biofilms

• Describe physiologic versus pathologic biofilms

• Define Phase-1 versus Phase-2 biofilms

• Describe Rx interventions for each

CME Effective Date:

Live Event: October 20th, 2026

CME Expiration Date:

Live Event: November 20th, 2026

Educational Credits:

1.5 AMA/PRA Category 1 CME Credit™
1.5 Nursing Contact Hours (1.5 Pharmacological)

Target Audience:

This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals

Conflict of Interest Disclosure Policy

Identify, Mitigate, and Disclose Relevant Financial Relationships

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.  The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases. speakers and committee members may be excluded.  All relevant financial relationships are disclosed to the learner below as required by the ACCME.

Disclosures:

Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.

Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.

Accreditation Statement:

Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s

In support of improving patient care, this activity has been planned and implemented by the Foundation for Care Management (FCM) and P S Anderson LLC. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This program is approved for 1.5 AMA Category 1 Credits^TM
This program is approved for 1.5 Nursing Contact Hours (1.5 Pharmacological)

Healthcare providers should only claim credit commensurate with the extent of their participation in this activity.